Stock Events

Stock Events

Wave Life Sciences 

$4.72
50
+$0.01+0.32% 14:22 Today

Statistics

Day High
4.76
Day Low
4.69
52W High
21.73
52W Low
4.65
Volume
8,554
Avg. Volume
-
Mkt Cap
929.08M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.34
-0.17
0.01
0.18
Expected EPS
-0.322352
Actual EPS
N/A

Financials

-478.33%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
42.73MRevenue
-204.38MNet Income

Analyst Ratings

20.22Average Price Target
The highest estimate is 43.00.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow WVE. It's not an investment recommendation.
AMD
10
AMD
Microsoft
8
MSFT
NVIDIA
8
NVDA
Coca-Cola
8
KO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alnylam Pharmaceuticals
ALNY
Mkt Cap31.73B
Alnylam Pharmaceuticals is a leading company in RNAi therapeutics, directly competing with Wave Life Sciences in the development of genetic disorder treatments.
Ionis Pharmaceuticals
IONS
Mkt Cap10.15B
Ionis Pharmaceuticals specializes in RNA-targeted drug discovery and development, making it a direct competitor in the same scientific field as Wave Life Sciences.
Arrowhead Pharmaceuticals
ARWR
Mkt Cap11.99B
Arrowhead Pharmaceuticals is involved in developing RNAi therapeutics for a variety of diseases, positioning it as a competitor in the RNA space alongside Wave Life Sciences.
Sarepta Therapeutics
SRPT
Mkt Cap2.2B
Sarepta Therapeutics is focused on the discovery and development of RNA-based therapeutics for rare diseases, making it a competitor in the same niche as Wave Life Sciences.
Moderna
MRNA
Mkt Cap55.09B
Moderna is known for its mRNA technology platform, which, while more famous for vaccines, also puts it in competition with Wave Life Sciences in the broader RNA therapeutics field.
Biomarin Pharmaceutical
BMRN
Mkt Cap12.52B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals for rare diseases, competing with Wave Life Sciences in targeting genetic disorders.
PTC Therapeutics
PTCT
Mkt Cap5.85B
PTC Therapeutics focuses on the discovery and commercialization of orally administered, small molecule therapeutics that modulate RNA, making it a competitor in the genetic disorder treatment market.

About

Vivint Solar, Inc. provides distributed solar energy primarily to residential customers in the United States. It owns and installs solar energy systems through long-term customer contracts. The company also sells photovoltaic installation products, as well as solar renewable energy certificates. As of December 31, 2019, it had an aggregate capacity of 1,294.0 megawatts covering approximately 188,300 homes. The company was formerly known as V Solar Holdings, Inc. and changed its name to Vivint Solar, Inc. in April 2014. Vivint Solar, Inc. was founded in 2011 and is headquartered in Lehi, Utah. As of October 8, 2020, Vivint Solar, Inc. operates as a subsidiary of Sunrun Inc.
Show more...
CEO
Mr. David H. Bywater
Employees
2998
Country
Singapore
ISIN
US94352A1043
WKN
000A1436W

Listings

STU
DE
1U5.STU
MU
DE
1U5.MU
XNAS
US
WVE
MU
DE
0VS.MU

0 Comments

Share your thoughts

FAQ

What is Wave Life Sciences stock price today?▼
The current price of WVE is $4.72 USD — it has increased by +0.32% in the past 24 hours. Watch Wave Life Sciences stock price performance more closely on the chart.
What is Wave Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Wave Life Sciences stocks are traded under the ticker WVE.
Is Wave Life Sciences stock price growing?▼
WVE stock has fallen by -6.05% compared to the previous week, the month change is a -21.08% fall, over the last year Wave Life Sciences has showed a -42.11% decrease.
What is Wave Life Sciences market cap?▼
Today Wave Life Sciences has the market capitalization of 929.08M
When is the next Wave Life Sciences earnings date?▼
Wave Life Sciences is going to release the next earnings report on November 05, 2026.
What were Wave Life Sciences earnings last quarter?▼
WVE earnings for the last quarter are -0.34 USD per share, whereas the estimation was -0.3 USD resulting in a -13.43% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Wave Life Sciences revenue for the last year?▼
Wave Life Sciences revenue for the last year amounts to 42.73M USD.
What is Wave Life Sciences net income for the last year?▼
WVE net income for the last year is -204.38M USD.
How many employees does Wave Life Sciences have?▼
As of September 04, 2026, the company has 2,998 employees.
In which sector is Wave Life Sciences located?▼
Wave Life Sciences operates in the Energy sector.
When did Wave Life Sciences complete a stock split?▼
Wave Life Sciences has not had any recent stock splits.
Where is Wave Life Sciences headquartered?▼
Wave Life Sciences is headquartered in Lehi, Singapore.